MedTrace Logo

Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial.

NCT00396513 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2006-11-07

No results posted yet for this study

Summary

The purpose of this study is to compare effects of statins (simvastatin) and metformin on clinical (menstrual cycle, excessive hair, skin problems), endocrine (androgens), metabolic (lipids, markers of systemic inflammation), and endothelial function parameters in women with polycystic ovary syndrome (PCOS).

Conditions

  • Polycystic Ovary Syndrome

Interventions

DRUG

Simvastatin

DRUG

Simvastatin and Metformin

DRUG

Metformin

Sponsors & Collaborators

  • Yale University

    collaborator OTHER

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Leszek Pawelczyk, MD PhD · Poznan University of Medical Scienses

  • Antoni J Duleba, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00396513 on ClinicalTrials.gov